Combination treatments for psoriasis: A systematic review and meta-analysis

Archives of Dermatology

Volumn 148, Issue 4, 2012, Pages 511-522

  Bailey, Elizabeth E ^a   Ference, Elisabeth H ^b   Alikhan, Ali ^d   Hession, Meghan T ^c   Armstrong, April W ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c SAINT JOSEPH HOSPITAL   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; BETA CAROTENE; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; ETRETIN; ETRETINATE; FOLIC ACID; METHOTREXATE; PSORALEN; RAPAMYCIN; RETINOL DERIVATIVE; SALICYLIC ACID; TACROLIMUS; TAR; TAZAROTENE; VITAMIN D DERIVATIVE;

BALNEOTHERAPY; COMBINATION CHEMOTHERAPY; COMPARATIVE EFFECTIVENESS; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENCY; HUMAN; HYDROCOLLOID DRESSING; LOW CALORY DIET; META ANALYSIS; MONOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION;

ADRENAL CORTEX HORMONES; BALNEOLOGY; BANDAGES, HYDROCOLLOID; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PSORIASIS; PUVA THERAPY; ULTRAVIOLET THERAPY; VITAMIN A; VITAMIN D; VITAMINS;

EID: 84859949990     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.1916     Document Type: Review

References (79)

1. Augustin M, Kruger K, Radtke MA, Schwippl I, Reich K. Disease severity, quality of life and health care in plaque-type psoriasis: amulticenter cross-sectional study in Germany. Dermatology. 2008;216(4):366-372. (Pubitemid 351630108)
2. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383-392. (Pubitemid 43128290)
3. Lebwohl MG, Corvari L. Compatibility of topical therapies for psoriasis: challenges and innovations. Cutis. 2007;79(1)(suppl 2):5-10.
4. Jensen P, Skov L, Zachariae C. Systemic combination treatment for psoriasis: a review. Acta Derm Venereol. 2010;90(4):341-349.
5. Koo JY. Using topical multimodal strategies for patients with psoriasis. Cutis. 2007;79(1)(suppl 2):11-17.
6. Mason AR, Mason J, Cork M, Dooley G, Edwards G. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev. 2009;(2):CD005028.
7. Jacob SE, Steele T. Corticosteroid classes: a quick reference guide including patch test substances and cross-reactivity. J Am Acad Dermatol. 2006;54(4):723-727.
8. Griffiths CE, Clark CM, Chalmers RJ, Li Wan Po A, Williams HC. A systematic review of treatments for severe psoriasis. Health Technol Assess. 2000;4(40): 1-125.
9. Egger M, Smith GD, Altman D, eds. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. London, England: BMJ Books; 2001.
10. Austad J, Bjerke JR, Gjertsen BT, et al. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. J Eur Acad Dermatol Venereol. 1998;11(1):19-24. (Pubitemid 28383610)
11. Katoh N, Kishimoto S. Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis. Eur J Dermatol. 2003;13 (4):382-384. (Pubitemid 36963099)
12. Koo J, Blum RR, Lebwohl M. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. J Am Acad Dermatol. 2006;55(4):637-641. (Pubitemid 44436646)
13. Kaufmann R, Bibby AJ, Bissonnette R, et al. A new calcipotriol/ betamethasone dipropionate formulation (DaivobetTM) is an effective once-daily treatment for psoriasis vulgaris. Dermatology. 2002;205(4):389-393. (Pubitemid 35356768)
14. Kragballe K, Barnes L, Hamberg KJ, et al. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br J Dermatol. 1998;139(4):649-654. (Pubitemid 28474311)
15. Kragballe K, Noerrelund KL, Lui H, et al. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol. 2004;150(6):1167- 1173. (Pubitemid 38932288)
16. Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial. Br J Dermatol. 2009;161(1):159-166.
17. Ortonne JP, Kaufmann R, Lecha M, Goodfield M. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial. Dermatology. 2004;209(4):308-313. (Pubitemid 39482622)
18. Papp KA, Guenther L, Boyden B, et al. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol. 2003;48(1):48-54. (Pubitemid 36091533)
19. Ruzicka T, Lorenz B. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Br J Dermatol. 1998;138(2):254-258. (Pubitemid 28114127)
20. Salmhofer W, Maier H, Soyer HP, Hönigsmann H, Hödl S. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis. Acta Derm Venereol Suppl (Stockh). 2000;(211):5-8. (Pubitemid 32156242)
21. Tzung TY, Chen CY, Yang CY, Lo PY, Chen YH. Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis. Acta Derm Venereol. 2008;88(3):279-280.
22. Bourke JF, Iqbal SJ, Hutchinson PE. The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. Clin Exp Dermatol. 1997;22(6):259-261. (Pubitemid 28070352)
23. 3 derivative tacalcitol increases the responsiveness to 311-nm ultraviolet B: results of a controlled, right/left study. Br J Dermatol. 2001;144(3):628-629.
24. Molin L; Calcipotriol-UVB Study Group. Topical calcipotriol combined with phototherapy for psoriasis: the results of two randomized trials and a review of the literature. Dermatology. 1999;198(4):375-381.
25. 3) does not augment UVB phototherapy for plaque psoriasis. J Am Acad Dermatol. 1996;35(2, pt 1):272-274.
26. Ramsay CA, Schwartz BE, Lowson D, Papp K, Bolduc A, Gilbert M; The Canadian Calcipotriol and UVB Study Group. Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and UVB-sparing antipsoriatric combination treatment. Dermatology. 2000;200(1):17-24. (Pubitemid 30088330)
27. Rim JH, Choe YB, Youn JI. Positive effect of using calcipotriol ointment with narrowband ultraviolet B phototherapy in psoriatic patients. Photodermatol Photoimmunol Photomed. 2002;18(3):131-134.
28. -1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study. Br J Dermatol. 2001;144(3):495-499.
29. Woo WK, McKenna KE. Combination TL01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial. Br J Dermatol. 2003;149(1):146-150. (Pubitemid 36966524)
30. Lauharanta J, Juvakoski T, Lassus A. A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis. Br J Dermatol. 1981;104(3):325-332. (Pubitemid 11060745)
31. Lawrence CM, Marks J, Parker S, Shuster S. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. Br J Dermatol. 1984; 110(2):221-226. (Pubitemid 14184214)
32. Macdonald K, Holti G, Marks J. Is there a place for beta-carotene/ canthaxanthin in photochemotherapy for psoriasis? Dermatologica. 1984;169(1):41-46. (Pubitemid 14083514)
33. Matsunami E, Takashima A, Mizuno N, Jinno T, Ito H. Topical PUVA, etretinate, and combined PUVA and etretinate for palmoplantar pustulosis: comparison of therapeutic efficacy and the influences of tonsillar and dental focal infections. J Dermatol. 1990;17(2):92-96. (Pubitemid 20191472)
34. Parker S, Coburn P, Lawrence C, Marks J, Shuster S. A randomized doubleblind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis. Br J Dermatol. 1984;110(2):215-220. (Pubitemid 14184213)
35. Saurat JH, Geiger JM, Amblard P, et al. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica. 1988;177(4):218-224.
36. Tanew A, Guggenbichler A, Hönigsmann H, Geiger JM, Fritsch P. Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. J Am Acad Dermatol. 1991;25(4):682-684.
37. Christiansen JV, Holm P, Møller R, Reymann F, Schmidt H. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis: a double-blind, randomized, multicenter trial. Dermatologica. 1982;165(3):204-207. (Pubitemid 12048625)
38. Gollnick H, Menter A. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis. Br J Dermatol. 1999;140(suppl 54):18-23. (Pubitemid 29191433)
39. Green L, Sadoff W. A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis. J Cutan Med Surg. 2002;6(2):95-102. (Pubitemid 34563761)
40. Lebwohl MG, Breneman DL, Goffe BS, et al. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. J Am Acad Dermatol. 1998; 39(4, pt 1):590-596. (Pubitemid 28465882)
41. Lebwohl M, Lombardi K, Tan MH. Duration of improvement in psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: comparison of maintenance treatments. Int J Dermatol. 2001;40(1):64-66. (Pubitemid 32201237)
42. Poulin YP. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study. Cutis. 1999;63(1):41-48.
43. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs etretinate (re- TL-01) vs etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol. 1992;127(1):5-9.
44. Koo JY, Lowe NJ, Lew-Kaya DA, et al. Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol. 2000;43(5, pt 1):821-828.
45. Lowe NJ, Prystowsky JH, Bourget T, Edelstein J, Nychay S, Armstrong R. Acitretin plus UVB therapy for psoriasis: comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol. 1991;24(4):591-594.
46. Ruzicka T, Sommerburg C, Braun-Falco O, et al. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis. Arch Dermatol. 1990; 126(4):482-486. (Pubitemid 20128961)
47. Brockow T, Schiener R, Franke A, Resch KL, Peter RU. A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. J Altern Complement Med. 2007;13(7):725-732. (Pubitemid 47585345)
48. Brockow T, Schiener R, Franke A, Resch KL, Peter RU. A pragmatic randomizedcontrolled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. J Eur Acad Dermatol Venereol. 2007;21(8):1027-1037. (Pubitemid 47304602)
49. Dawe RS, Yule S, Cameron H, Moseley H, Ibbotson SH, Ferguson J. A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs narrowband ultraviolet B monotherapy for chronic plaque psoriasis. Br J Dermatol. 2005;153(3):613-619. (Pubitemid 41248222)
50. Gambichler T, Rapp S, Senger E, Altmeyer P, Hoffmann K. Balneophototherapy of psoriasis: highly concentrated salt water versus tap water: a randomized, one-blind, right/left comparative study. Photodermatol Photoimmunol Photomed. 2001; 17(1):22-25. (Pubitemid 32096720)
51. Léauté-Labrèze C, Saillour F, Chêne G, et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: lessons from the Salies de Béarn randomized study. Arch Dermatol. 2001;137(8):1035-1039. (Pubitemid 32756461)
52. Legat FJ, Hofer A, Wackernagel A, et al. Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis. Arch Dermatol. 2007;143(8):1016-1022. (Pubitemid 47296078)
53. Ortonne JP, Khemis A, Koo JY, Choi J. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis. J Eur Acad Dermatol Venereol. 2005;19(5):556-563.
54. Jacobe H, Winterfield L, Kim F, Huet-Adams B, Cayce R. The role of narrowband UV-B plus alefacept combination therapy in the treatment of psoriasis [comment]. Arch Dermatol. 2008;144(8):1067-1068.
55. Legat FJ, Hofer A, Wackernagel A, et al. The role of narrowband UV-B plus alefacept combination therapy in the treatment of psoriasis [reply]. Arch Dermatol. 2008;144(8):1068-1069.
56. Asawanonda P, Nateetongrungsak Y. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaquetype psoriasis: a randomized, placebo-controlled study. J Am Acad Dermatol. 2006;54(6):1013-1018.
57. Mahajan R, Kaur I, Kanwar AJ. Methotrexate/narrowband UVB phototherapy combination vs narrowband UVB phototherapy in the treatment of chronic plaquetype psoriasis: a randomized single-blinded placebo-controlled study. J Eur Acad Dermatol Venereol. 2010;24(5):595-600.
58. Amornpinyokeit N, Asawanonda P. 8-Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis. Photodermatol Photoimmunol Photomed. 2006;22(6):285-289. (Pubitemid 44712304)
59. Seckin D, Usta I, Yazici Z, Senol A. Topical 8-methoxypsoralen increases the efficacy of narrowband ultraviolet B in psoriasis. Photodermatol Photoimmunol Photomed. 2009;25(5):237-241.
60. Bagel J. LCD plus NB-UVB reduces time to improvement of psoriasis vs NBUVB alone. J Drugs Dermatol. 2009;8(4):351-357.
61. Menkes A, Stern RS, Arndt KA. Psoriasis treatment with suberythemogenic ultraviolet B radiation and a coal tar extract. J Am Acad Dermatol. 1985;12(1, pt 1):21-25. (Pubitemid 15188839)
62. Agius A, Borg E, Pace JL. The value of colloid dressings in psoriasis. Adv Exp Med Biol. 1999;455:377-385. (Pubitemid 32187489)
63. Kragballe K, Larsen FG. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis. Acta Derm Venereol. 1991;71(6):540-542.
64. Volden G, Kragballe K, Van De Kerkhof PC, Aberg K, White RJ. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone. J Dermatolog Treat. 2001;12(3):141-144. (Pubitemid 33116875)
65. Koo J, Cuffie CA, Tanner DJ, et al. Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderateto- severe psoriasis: a multicenter study. Clin Ther. 1998;20(2):283-291. (Pubitemid 28241748)
66. Tiplica GS, Salavastru CM. Mometasone furoate 0.1% and salicylic acid 5% vs mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009;23(8):905-912.
67. Dover JS, McEvoy MT, Rosen CF, Arndt KA, Stern RS. Are topical corticosteroids useful in phototherapy for psoriasis? J Am Acad Dermatol. 1989;20(5, pt 1):748-754. (Pubitemid 19127910)
68. Larkö O, Swanbeck G, Svartholm H. The effect on psoriasis of clobetasol propionate used alone or in combination with UVB. Acta Derm Venereol. 1984; 64(2):151-154. (Pubitemid 14130456)
69. Ezquerra GM, Regaña MS, Millet PU. Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis. Acta Derm Venereol. 2007;87(5):449-450. (Pubitemid 351373434)
70. Giannetti A, Coppini M, Bertazzoni MG, et al. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderatesevere psoriasis. J Eur Acad Dermatol Venereol. 1999;13(2):91-95. (Pubitemid 29472346)
71. Rim JH, Park JY, Choe YB, Youn JI. The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy. Am J Clin Dermatol. 2003;4(7):507-510. (Pubitemid 36871768)
72. van de Kerkhof PC, Cambazard F, Hutchinson PE, et al. The effect of addition of calcipotriol ointment (50 μg/g) to acitretin therapy in psoriasis. Br J Dermatol. 1998;138(1):84-89. (Pubitemid 28077942)
73. Carroll CL, Clarke J, Camacho F, Balkrishnan R, Feldman SR. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. Arch Dermatol. 2005;141(1):43-46. (Pubitemid 40144438)
74. Gisondi P, Del Giglio M, Di Francesco V, Zamboni M, Girolomoni G. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigatorblinded clinical trial. Am J Clin Nutr. 2008;88(5):1242-1247.
75. Reitamo S, Spuls P, Sassolas B, Lahfa M, Claudy A, Griffiths CE; Sirolimus European Psoriasis Study Group. Efficacy of sirolimus (Rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Br J Dermatol. 2001;145(3):438-445. (Pubitemid 32953701)
76. Salim A, Tan E, Ilchyshyn A, Berth-Jones J. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebocontrolled trial. Br J Dermatol. 2006;154(6):1169-1174. (Pubitemid 43727401)
77. Zachariae C, Mørk NJ, Reunala T, et al. The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy. Acta Derm Venereol. 2008;88(5):495-501.
78. Marsland AM, Chalmers R, Hollis S, Leonardi-Bee J, Griffiths CE. Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev. 2006;(1): CD001433.
79. Pocock SJ, Ware JH. Translating statistical findings into plain English. Lancet. 2009;373(9679):1926-1928.